Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells

Clinical Cancer Research

Volumn 10, Issue 10, 2004, Pages 3422-3428

  Reimers, Natalie ^a   Zafrakas, Kristine ^a   Assmann, Volker ^a   Egen, Cornelia ^a   Riethdorf, Lutz ^a   Riethdorf, Sabine ^a   Berger, Jürgen ^a   Ebel, Sebastian ^a   Jänicke, Fritz ^a   Sauter, Guido ^b   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CYTOKERATIN; ESTROGEN RECEPTOR; GELATINASE A; IMMUNOGLOBULIN; INTERSTITIAL COLLAGENASE; PROGESTERONE RECEPTOR; STROMELYSIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW METASTASIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER GRADING; CONFIDENCE INTERVAL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; TUMOR GROWTH; TUMOR VOLUME;

ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; BONE MARROW CELLS; CELL LINE, TUMOR; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOPLASM METASTASIS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, PROGESTERONE; RISK; RISK FACTORS; TIME FACTORS;

EID: 2542432100     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0610     Document Type: Article

References (22)

1. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002;21:2245-52.
2. Egeblad M, Werb Z. New function for the matrix metalloproteases in cancer progression. Nat Rev Cancer 2002;2:163-76.
3. Ellis SM, Nabeshima K, Biswas C. Monoclonal antibody preparation and purification of a tumor cell collagenase stimulatory factor. Cancer Res 1989;49:3385-91.
4. Muramatsu T, Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003;18:981-7.
5. Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M. Gelatinase A, membrane typ 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 2000;24:334-40.
6. Kataoka H, DeCastro R, Zucker S, Biswas C. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993;53:3154-8.
7. Berditchevski F, Chang S, Bodorova J, Hemler ME. Generation of monoclonal antibodies to integrin-associated proteins. J Biol Chem 1997;272:29174-80.
8. Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001;61:2276-81.
9. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001;158:1921-8.
10. Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol 2002;30:1365-72.
11. Stockinger H, Ebel T, Hansmann C, et al. CD147 (neurothelin/basigin) workshop panel report. In: Kishimoto K, editor. Leukocyte typing, Vol. 6. London: Garland Press; 1997. p. 760.
12. Koch C, Staffler G, Hüttinger R, et al. T-Cell activation-associated epitopes of CD147 in regulation of the T-cell response, and their definition by antibody affinity and antigen density. Int Immunol 1999;11:777-86.
13. Schraml P, Bucher C, Bissig H, et al. Cyclin E overexpression and amplification in human tumours. J Pathol 2003;200:375-82.
14. Braun S, Pantel K, Mueller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
15. Woelfle U, Cloos J, Sauter G, et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003;63:5679-84.
16. Bernards R, Weinberg RA. A progression puzzle. Nature (Lond.) 2002;418:823.
17. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
18. Noguchi Y, Sato T, Hiratam M, Hara T, Ohama K, Ito A. Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro. J Clin Endocrinol Metab 2003;88:6063-72.
19. Xiao LJ, Chang H, Ding NZ, Ni H, Kadomatsu K, Yang ZM. Basigin expression and hormonal regulation in mouse uterus during the peri-implantation period. Mol Reprod Dev 2002;63:47-54.
20. Xiao LJ, Diao HL, Ma XH, et al. Basigin expression and hormonal regulation in the rat uterus during the peri-implantation period. Reproduction 2002;124:219-25.
21. Klein CA, Seidl S, Petat-Dutter K, et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol 2002;20:387-92.
22. Caudroy S, Polette M, Tournier JM, et al. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 1999;12:1575-80.